Literature DB >> 8452558

Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes.

N L Kerry1, A A Somogyi, G Mikus, F Bochner.   

Abstract

The O-demethylation of dextromethorphan (DM) to dextrorphan (DR) is catalysed by the polymorphic CYP2D6 (cytochrome P4502D6) isozyme in man. DM is commonly used as a probe for phenotyping subjects as either poor or extensive metabolizers for the debrisoquine/sparteine oxidative polymorphism via CYP2D6. The enzyme kinetics of DM O- and N-demethylation, and the N- and O-demethylations of the primary metabolites DR and 3-methoxymorphinan (3MM), respectively, were studied in liver microsomes from female Dark Agouti (DA) rats, the poor metabolizer counterpart, and female Sprague-Dawley (SD) rats, the extensive metabolizer counterpart. The formation of metabolites was quantified by HPLC with fluorescence detection and kinetic parameters were calculated. The intrinsic clearance (Vmax/Km) of the O-demethylation of 3MM to 3-hydroxymorphinan (3OHM) was 180-fold lower in DA rats (0.11 vs 20.77 mL/hr/mg) due to a 60-fold higher Km (108.7 vs 1.76 microM) and 3-fold lower Vmax (11.5 vs 35.95 nmol/mg/hr). The kinetics for DR N-demethylation to 3OHM did not differ between rat strains. The Michaelis-Menten constant (Km) for DM N-demethylation to 3MM was similar between SD and DA rats (85.04 vs 68.99 microM); however, SD rats displayed a 2-fold higher Vmax (83.37 vs 35.49 nmol/mg/hr) and intrinsic clearance (0.96 vs 0.51 mL/hr/mg). The O-demethylation of DM to DR in SD rats showed a high and low affinity enzyme component, with the high affinity intrinsic clearance contributing 98% of the total intrinsic clearance in these rats. DM O-demethylation in DA rats was characterized by a single enzyme system. The high affinity O-demethylating enzyme in SD rats showed a 20-fold lower Km (2.5 vs 55.6 microM) and a three-fold higher Vmax (51.04 vs 16.84 nmol/mg/hr) resulting in a 66-fold higher intrinsic clearance (20.04 vs 0.31 mL/hr/mg) compared to DA rats. Quinine, dextropropoxyphene, (+/-)methadone and (+/-)propafenone were shown to be potent inhibitors of 3MM and DM O-demethylation but did not inhibit DR or DM N-demethylation at similar concentrations. SD and DA rats showed a clear strain difference in 3MM O-demethylation and DM O-demethylation. In contrast, DR N-demethylation and DM N-demethylation do not appear to be under genetic control in the female SD-DA rat model. Kinetic parameters and inhibition studies suggest that 3MM and DM O-demethylation pathways in the rat may be mediated by the same cytochrome P450 isozyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452558     DOI: 10.1016/0006-2952(93)90166-t

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation.

Authors:  Nadja Grobe; Toni M Kutchan; Meinhart H Zenk
Journal:  FEBS Lett       Date:  2012-05-26       Impact factor: 4.124

2.  First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.

Authors:  Kaidi Zhou; Jibran Y Khokhar; Bin Zhao; Rachel F Tyndale
Journal:  Biochem Pharmacol       Date:  2013-04-23       Impact factor: 5.858

3.  Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.

Authors:  M Dostalek; E Hadasova; M Hanesova; J Pistovcakova; A Sulcova; J Jurica; J Tomandl; I Linhart
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

4.  Dextromethorphan differentially affects opioid antinociception in rats.

Authors:  Shiou-Lan Chen; Eagle Yi-Kung Huang; Lok-Hi Chow; Pao-Luh Tao
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.

Authors:  N L Kerry; A A Somogyi; F Bochner; G Mikus
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

6.  Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice.

Authors:  Yune-Fang Ueng; Chien-Chih Chen; Yu-Ling Huang; I-Jung Lee; Chul-Ho Yun; Yu-Hsuan Chen; Chiung-Chiao Huang
Journal:  J Food Drug Anal       Date:  2015-05-21       Impact factor: 6.157

7.  The time-dependent effects of St John's wort on cytochrome P450, uridine diphosphate-glucuronosyltransferase, glutathione S-transferase, and NAD(P)H-quinone oxidoreductase in mice.

Authors:  Jin-Fu Yang; Yue-Rong Liu; Chiung-Chiao Huang; Yune-Fang Ueng
Journal:  J Food Drug Anal       Date:  2017-02-14       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.